LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 12.55
-0.75 (-5.64%)
Nov 6, 2026, 1:21 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 407.31 million as of November 6, 2026. It is the 40,006th most valuable company in the world and the 2,300th biggest in Taiwan. Its market cap has decreased by 45.55% in one year.
Market Cap
407.31M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,300 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 407.31M, a decrease of -43.51%. That is a compound annual growth rate of -18.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 408.93M | -46.15% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 870.50M |
| Lukas Biomedical | 753.74M |
| NatureWise Biotech & Medicals | 722.00M |
| BioLASCO Taiwan | 720.98M |
| Neith | 624.81M |
| Taiwan Advance Bio-Pharmaceutical | 609.30M |
| SynCore Biotechnology Co.,Ltd | 583.74M |
| Vectorite Biomedical | 498.99M |